Agilent Presents Early Career Professor Award to Dr. Gary Patti
News Jul 11, 2017
Agilent Technologies has named Dr. Garry J. Patti, as the recipient of the prestigious 2017 Agilent Early Career Professor Award.
Dr. Patti, Associate Professor, Department of Chemistry Arts and Science, Washington University in St. Louis, was selected for his contributions to the detection of metabolomics changes in whole organisms and their utility for drug discovery, early detection, characterization and surveillance of cancer as well as other diseases and conditions.
Using state-of-the-art mass spectrometers coupled with cutting-edge metabolomic technologies, Dr. Patti’s lab takes a systems-level approach to the study of comprehensive metabolism and identification of specific pathways that are altered in connection with particular phenotypes.
“Agilent is pleased to recognize and support the work of Dr. Patti, who is developing and implementing experimental approaches that advance metabolomics analysis from the lab bench to translational applications in human disease,” said Jack Wenstrand, Director, University Relations and External Research at Agilent.
"Metabolism is one of the most exciting areas in biochemical research. We are honored to have one of the world's best in metabolomics here in our department," said Dr. William Buhro, Chairman, Department of Chemistry; George E. Pake Professor in Arts & Science Washington University in St. Louis.
The annual Agilent Early Career Professor Award was established in 2008. Through this award, Agilent seeks to recognize the achievements of academic researchers in the initial stages of their careers and to support and develop strong collaborative relationships with them at the beginning of their professional lives. This award underscores Agilent's commitment to furthering research through the company's products and services, financial support, and collaborative engagement by Agilent scientists and engineers.
This article has been republished from materials provided by Agilent Technologies. Note: material may have been edited for length and content. For further information, please contact the cited source.
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV DrugNews
Supplies of a promising drug for cancer, HIV and possibly other diseases is dwindling, and scientists have struggled to extract more from the marine creatures who produce it. Now, chemists have a synthetic solution.READ MORE
Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain CancerNews
Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.READ MORE
New Drug Class: Potential Therapeutics for Alzheimer’s Disease?News
One step closer to an Alzheimer's treatment? Novel class of drugs more precisely blocks production of toxic forms of beta-amyloid.READ MORE